MARKET

CME

CME

Cme Group Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

199.93
+3.02
+1.53%
After Hours: 199.93 0 0.00% 16:19 05/27 EDT
OPEN
198.83
PREV CLOSE
196.91
HIGH
199.94
LOW
197.51
VOLUME
1.12M
TURNOVER
0
52 WEEK HIGH
256.94
52 WEEK LOW
183.15
MARKET CAP
71.86B
P/E (TTM)
26.15
1D
5D
1M
3M
1Y
5Y
$100 Invested In CME Group 10 Years Ago Would Be Worth This Much
CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 2.35% on an annualized basis producing an average annual return of 14.45%. Currently, CME Group has a market capitalization of $71.41 billion.
Benzinga · 21h ago
Why Is CME (CME) Down 12.8% Since Last Earnings Report?
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 22h ago
CME Group upgraded to Outperform at Oppenheimer as a defensive play
CME Group (NASDAQ:CME) stock is rising 1.6% in early Wednesday trading after Oppenheimer analyst Owen Lau upgraded the company to Outperform from Perform, taking a defensive angle predicated on the assumption that
Seekingalpha · 3d ago
Here's Why Should You Stay Invested in CME Group (CME) Stock
Compelling portfolio, driving higher clearing and transaction fees, as well as improving non-transactional revenues should continue to drive CME Group (CME).
Zacks · 3d ago
Oppenheimer Upgrades CME Group to Outperform From Perform, Sets $223 Price Target
MT Newswires · 3d ago
Elon Musk responds to Tesla's ESG boot amid calls for a buyback
As the market continues to crater, many of the once-loved names on Wall Street are getting hammered, like tech darling and retail favorite Tesla (NASDAQ:TSLA). Sliding another 2.8% to $690/share in premarket
Seekingalpha · 05/19 09:46
Deutsche Bank Adjusts CME Group's Price Target to $210 From $262, Maintains Hold Rating
MT Newswires · 05/19 09:16
Baron Funds: “We Continue to Own CME Due to its Strong Competitive Moats”
Baron Funds, an asset management firm, published its “Baron Durable Advantage Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. Baron Durable Advantage Fund (the “Fund”) declined 10.3% (Institutional Shares) during the firs...
Insider Monkey · 05/18 14:00
More
No Data
Learn about the latest financial forecast of CME. Analyze the recent business situations of Cme Group Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

14.29%Strong Buy
23.81%Buy
57.14%Hold
4.76%Under-perform
0.00%Sell
Analyst Price Target
The average CME stock price target is 250.31 with a high estimate of 284.00 and a low estimate of 200.00.
High284.00
Average250.31
Low200.00
Current 199.93
EPS
Actual
Estimate
0.531.051.582.11
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 1.56K
Institutional Holdings: 348.44M
% Owned: 96.94%
Shares Outstanding: 359.42M
TypeInstitutionsShares
Increased
420
15.12M
New
160
1.20M
Decreased
344
11.03M
Sold Out
58
1.54M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Financial & Commodity Market Operators & Service Providers
+2.50%
Investment Banking & Investment Services
+2.28%
Key Executives
Chairman/Chief Executive Officer/Executive Director
Terrence Duffy
Vice Chairman/Independent Director
Charles Carey
Chief Financial Officer
John Pietrowicz
Corporate Executive
Sunil Cutinho
Chief Human Resource Officer/Senior Managing Director
Hilda Piell
Chief Accounting Officer/Managing Director
Jack Tobin
Chief Information Officer/Senior Managing Director
Kevin Kometer
General Counsel/Senior Managing Director/Secretary
Kathleen Cronin
Senior Managing Director/Chief Operating Officer
Julie Holzrichter
Senior Managing Director
Lynne Fitzpatrick
Senior Managing Director
Derek Sammann
Senior Managing Director
Sean Tully
Senior Managing Director
Kendal Vroman
Senior Managing Director
Julie Winkler
Lead Director/Independent Director
Daniel Glickman
Director
Michael Dennis
Director
Bryan Durkin
Independent Director
Timothy Bitsberger
Independent Director
Dennis Chookaszian
Independent Director
Elizabeth Cook
Independent Director
Ana Dutra
Independent Director
Martin Gepsman
Independent Director
Larry Gerdes
Independent Director
William Hobert
Independent Director
Daniel Kaye
Independent Director
Phyllis Lockett
Independent Director
Deborah Lucas
Independent Director
Patrick Maloney
Independent Director
Patrick Mulchrone
Independent Director
Terry Savage
Independent Director
Rahael Seifu
Independent Director
William Shepard
Independent Director
Howard Siegel
Independent Director
Dennis Suskind
Independent Director
Robert Tierney
No Data
No Data
About CME
CME Group Inc., through its exchanges, provides products across all asset classes, by trading futures, options, cash and over-the-counter (OTC) products. It offers the range of products across interest rates, equity indexes, foreign exchange (FX), agricultural commodities, energy and metals. It also offers cash and repo fixed income trading via BrokerTec, and cash and OTC FX trading via electronic broking services (EBS). Its segment consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) exchanges and NEX Group Limited (NEX). The Company provides electronic trading around the globe on its CME Globex platform. The Company also offers clearing and settlement services for a range of exchange-traded futures and options on futures contracts and over-the-counter derivatives.

Webull offers kinds of CME Group Inc stock information, including NASDAQ:CME real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CME stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CME stock methods without spending real money on the virtual paper trading platform.